Is the outlook grey for WR-2721 as a clinical radioprotector?
D004999:Amifostine / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*
D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D004999:Amifostine